The first 11 nucleotides of the 3' noncoding sequence of influenza virus cRNA contain the minimum promoter for virion RNA synthesis, which overlaps with other essential cis elements in vivo.
Answers are grounded in this paper and cite their sources.
May inform influenza antiviral design; leaves open human translation from animal data.
An in vitro RNA synthesis system was established in which the influenza virus virion (minus-sense) RNA was made from the synthetic plus-sense RNA (cRNA) template by the purified viral polymerase complex. The cRNA promoter was studied by mutational analysis using the in vitro system, and on the basis of these experiments, the first 11 nucleotides of the 3' noncoding sequence were found to contain the minimum promoter required for virion RNA synthesis. The addition of extra nucleotides at the 3' end decreased the promoter activity of the templates, indicating that the viral polymerase does not recognize an internal promoter efficiently. The wild-type and mutated RNA templates were also tested in vivo by using the ribonucleoprotein transfection system. In contrast to the in vitro system, it was found that the majority of mutations at the 3'-terminal sequence significantly decreased or abolished chloramphenicol acetyltransferase (CAT) expression. These results suggest that the cRNA promoter overlaps other essential cis elements required for chloramphenicol acetyltransferase expression in vivo.
No takes yet. Share an insight, caveat, or question.
Li et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: